|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED
Nominal 
38.880 +4.200 (+12.111%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -5.050% | -19.408% | -13.634% | -3.730% | -14.285% |
| ROAE (%) | -6.351% | -23.036% | -15.899% | -4.283% | -15.844% |
| Return on Capital Employed (%) | -4.845% | -25.001% | -15.512% | -4.305% | -15.822% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 69.252% | 74.558% | 72.673% | 63.688% | 57.407% |
| EBITDA Margin (%) | -26.057% | -138.788% | -676.639% | -1855.769% | -1854925.926% |
| Pre-tax Profit Margin (%) | -35.060% | -147.362% | -670.571% | -1933.044% | -1867998.148% |
| Net Profit Margin (%) | -17.447% | -147.362% | -670.571% | -1933.107% | -1867998.148% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 4.892 X | 2.540 X | 7.628 X | 3.924 X | 9.945 X |
| Quick Ratio (X) | 4.845 X | 2.522 X | 7.570 X | 3.911 X | 9.944 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 22.403% | 17.868% | 13.929% | 14.517% | 11.343% |
| Total Debt / Total Assets (%) | 13.552% | 11.076% | 8.845% | 7.615% | 7.298% |
| Net Debt / Total Assets (%) | -13.433% | -6.760% | -0.215% | 0.195% | -32.427% |
| Total Debt / Shareholders' Funds (%) | 17.465% | 13.486% | 10.277% | 8.908% | 8.232% |
| Long Term Debt / Shareholders' Funds (%) | 15.694% | 2.127% | 9.445% | 1.049% | 7.753% |
| Net Debt / Shareholders' Funds (%) | -17.311% | -8.231% | -0.250% | 0.229% | -36.575% |
| Net Cash / (Debt) ($) | 918.109M | 335.226M | 12.437M | (12.927M) | 2.155B |
| Net Cash / (Debt) per share ($) | 2.597 | 1.027 | 0.038 | (0.041) | 7.219 |
| Total Debt / Capital Employed (%) | 15.073% | 13.186% | 9.380% | 8.768% | 7.608% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 16.103 Day | 33.523 Day | 162.173 Day | 474.775 Day | 7093.696 Day |
| Receivables Turnover (Day) | 92.346 Day | 106.769 Day | 79.810 Day | 75.086 Day | 331.204 Day |
| Payables Turnover (Day) | 26.727 Day | 24.536 Day | 135.337 Day | 1400.479 Day | 319016.759 Day |
| Remarks: | Real time quote last updated: 27/03/2026 13:32 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -297,766 |
| %Change | -71.406% |
| EPS / (LPS) | RMB -0.890 |
| NBV Per Share (¥) | RMB 15.000 |